Cat.#: BBM-3C-048
Description | Rat Tail Collagen Type I, High Concentration, Sterile, Filtered, from Ace Therapeutics is a highly concentration, purified collagen derived from the rat tail. This product is more suitable for 3D cell culture due to the high concentration improves matrix stiffness and support integrity. |
Source | Rar tail |
Size | 100 mg |
Form | Lyophilized |
Purity | ≥90% (SDS-PAGE) |
Sterility | Passed test for bacteria, fungi, and mycoplasma. |
Storage | −20°C for 2 years. |
Shipping | Dry ice |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Description | Price |
---|---|---|---|
BBM-3C-056 | Porcine Gelatine |
Porcine Gelatine from Ace Therapeutics is a purified gelatin matrix from porcine tissue. The product can enhance the adsorption of various normal cells and transfected cells.
|
inquiry |
BBM-3C-042 | Collagen Type IV (Human Placenta) |
Collagen Type IV (Human Placenta) from Human Cell Culture from Ace Therapeutics is derived from human placenta and is highly purified native, type IV collagen.
|
inquiry |
BBM-3C-064 | Collagen, Type I, from Rat Tail |
The rat tail collagen I provided by Ace Therapeutics is prepared according to the Birkedal-Hansen method through acetic acid extraction, sodium chloride precipitation, and disodium hydrogen phosphate precipitation. This product is derived from a rat tail, dissolved in 0.02M HAc solution, and the purity is greater than 90% as determined by SDS-PAGE, and it is sterile.
|
inquiry |
BBM-3C-035 | Human Collagen Type V, 0.1mg |
Human Collagen Type V, 0.1mg from Ace Therapeutics is purified from human placenta.
Type V collagen, a fibrillar collagen, is critical for the fibrillation of types I and III collagen, contributing to optimal fibril formation and tissue quality.
|
inquiry |
BBM-3C-029 | Bovine Collagen Type III, 10 mg |
Bovine Collagen Type III, 10 mg from Ace Therapeutics is purified from bovine (calf ) skin.
Type III collagen is the second most abundant collagen in tissues and is found most commonly in tissues exhibiting elastic properties such as skin, lungs, intestinal walls, and walls of blood vessels, which resembles other fibrillar collagens in structure and function.
|
inquiry |
BBM-3C-023 | Porcine Collagen Type I and III, 10 mg |
Porcine Collagen Type I and III, 10 mg from Ace Therapeutics is purified from pig’s tissue.
Type I collagen is the most abundant collagen and is found in connective tissues including tendons, ligaments, dermis, and blood vessels. Type III collagen is the second most abundant collagen in tissues and is found most commonly in tissues exhibiting elastic properties such as skin, lungs, intestinal walls, and walls of blood vessels, which resembles other fibrillar collagens in structure and function.
|
inquiry |
BBM-3C-039 | Rat Tail Collagen Type I (from Rat Tail Tendon) |
Rat Tail Collagen Type I (from Rat Tail Tendon) from Ace Therapeutics is purified from rat tail by the Birkedal-Hansen method. This product has the advantages of high purity (SDS-PAGE>85%), low endotoxin, and easy storage and transportation, making it convenient for customers to prepare the required concentration.
|
inquiry |
BBM-3C-050 | Bovine Collagen Type I |
Bovine Collagen Type I from Ace Therapeutics is a purified collagen derived from bovine tissue. The native collagen sequence contained in the preparation is missing or shortened since this product has been treated with pepsin.
|
inquiry |
BBM-3C-034 | Human Collagen Type IV, 0.1mg |
Human Collagen Type IV, 0.1mg from Ace Therapeutics is purified from human cartilage.
|
inquiry |
BBM-3C-038 | Rat Tail Collagen Type I |
Rat Tail Tendon Collagen Type I from Ace Therapeutics is purified from rat tail by the Birkedal-Hansen method. This product can form a three-dimensional glue with a certain strength when the concentration is above 1mg/mL and the pH is around 7.
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.